2010 Sees Launch of Groundbreaking New Cataract Lens


Having been approved by the Food and Drug Administration (FDA), Bausch & Lomb look set to pioneer cataract surgery with their lens Crystalens® AO. The lens boasts the ability to not only remove the cataract but to improve the patient’s vision after surgery; with many of them finding wearing glasses unnecessary. Combining years worth of research and refined products, the company hope this lens is to become favoured by surgeons and patients alike.

The natural lens of the eye is what is affected when a cataract occurs as an intraocular lens replaces the natural one, creating the cloudy appearance that we sometimes associate with cataracts. This new Crystalens is also an intraocular lens placed within the eye to eradicate the effects of the cataract lens. The surgery for inserting this lens is no more complicated than a normal cataract removal surgery; the same incision is used to inject the lens into the eye.

One area of the lens that has raised a few eyebrows is its use of aspheric optics, which in previous studies have been thought to reduce the depth of field that the patient can see. However, Bausch & Lomb remain positive, as surgical president of the group, Andy Corley adds: this aspheric lens hasn’t been created the same as other types of aspheric lenses, as previously many of them have had negative spherical aberration (when light isn’t focused correctly) but this lens has zero negative spherical aberration.

With millions of cataract surgeries needed worldwide each year, it is hoped that Bausch & Lomb’s prestigious status as one of the leading healthcare brands worldwide, will be able to bring a new dimension of vision to many of these patients. With its ease of surgery, it is also hoped that many surgeons will favour this routine in the next coming months.

14th January 2010

<<<more cataract news


Laser Eye Surgery Enquiry Form

Complete this form if you would like information about laser eye surgery including costs & suitablity.